Provider: ingentaconnect Database: ingentaconnect Content: application/x-research-info-systems TY - ABST AU - Fenjves, Elizabeth S. AU - Ochoa, M. Sofia AU - Gay-Rabinstein, Carlota AU - Ricordi, Camillo AU - Curran, Michael A. TI - Retrovirally Transferred Genes Inhibit Apoptosis in an Insulin-Secreting Cell Line: Implications for Islet Transplantation JO - Cell Transplantation PY - 2004-01-01T00:00:00/// VL - 13 IS - 5 SP - 489 EP - 496 KW - Apoptosis KW - Gene delivery KW - Insulinoma cell line KW - Islet transplantation KW - NIT-1 N2 - The transplantation of pancreatic islets for the treatment of type I diabetes is hindered by the enormous loss of cells due to early apoptotic events. Genetic engineering of islets with cytoprotective genes is an important strategy aimed to enhance the survival of these cells in the transplant setting. The present study was designed to evaluate and compare the effects of five genes on a cell line derived from insulin-producing β-cells, NIT-1. Cells were transduced using a Maloney murine leukemia virus (MLV) vector coding for yellow fluorescent protein (YFP) and for one of the following antiapoptotic genes: cFLIP, FADD-DN, BcL-2, PI-9, and ICAM-2. These genes were able to protect NIT-1 cells from cytokine-induced apoptosis to varying degrees ranging from no protection to significant protection equivalent to an optimal dose of a chemical caspase inhibitor. The data demonstrate that cFLIP, FADD-DN, and PI-9 are significantly more effective in protecting NIT-1 cells than BcL-2 and ICAM-2. Additionally, the data show that despite its weak in vitro inhibition of caspase-3, PI-9 affords significant protection against TNF-α-induced apoptosis in these cells. These genes may be ideal candidates to augment islet survival following transplantation. UR - M3 - doi:10.3727/000000004783983710 UR - ER -